Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults

NCT ID: NCT02496858

Last Updated: 2019-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-12

Study Completion Date

2022-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to identify genetic loci,or gene variations contributing to the development of coronary artery disease (CAD) in Chinese young adults. Investigators will compare coronary angiogram results to genetic findings within young CAD patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During last 10 years, the rise in coronary artery disease (CAD) prevalence in Chinese young adults is observed and percutaneous coronary intervention (PCI) is generally considered to be low operative risk in these young patients. Genome-wide association studies have identified a considerable number of common genetic variants related to CAD. However, the extent to which these genetic variants are related to the future cardiovascular events, the prevalence, extent, severity, and prognosis of young patients with CAD is not clear.

The aim of this study is to investigate the genetic loci, or gene variations contributing to the development and prognosis of CAD in Chinese young adult. Investigators will compare the angiogram results to genetic findings first in patients with different stages of CAD. Then, investigators will collect patients from hospital discharge registry, and compare long-term outcome as well as on operative details in different gene groups.

The results of the study provide a possibility to develop a gene test to recognize patients at risk at its early stage, and needing for preventive medicine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Percutaneous Coronary Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early-onset CAD

The anticipated 2000 young CAD patients who aged ≤45years undergoing coronary angiography will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.

No interventions assigned to this group

Late-onset CAD

The anticipated 2000 old CAD patients aged≥65years undergoing coronary angiography will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.

No interventions assigned to this group

Age-matched controls

The anticipated 2000 control subjects without obvious coronary stenosis aged≤45years or ≥65years will be recruited in the prospective cohort. Medical history and risk-factor information were obtained by interviewing patients and by abstracting information from medical records.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. premature CAD, includes patients who aged ≥ 18 and ≤ 45 years , and with at least one main coronary artery stenosis ≥ 50% confirmed by coronary angiography, involving left main coronary artery, left anterior descending branch, left circumflex branch or right coronary artery, and manifested as occult CAD, stable CAD, unstable angina pectoris, non-ST segment elevated myocardial infarction and ST segment elevated myocardial infarction;
2. mature CAD, refers to patients who aged ≥ 65 years and meat the same CAD diagnostic criteria as above;
3. age matched individuals who had coronary arteries without obvious stenosis.

Exclusion Criteria

1. severely sick with limited life-expectancy \< 1 year;
2. patients with malignancies;
3. pregnant or planning for pregnancy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Zhongshan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Junbo Ge

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Xiamen Cardiovascular Hospital

Xiamen, Fujian, China

Site Status RECRUITING

The First Hospital of Lanzhou University

Lanzhou, Gansu, China

Site Status RECRUITING

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

Site Status RECRUITING

Sun yat-sen Memorial Hospital

Guangzhou, Guangdong, China

Site Status RECRUITING

Zhuhai Hospital of Guangdong Provincial People's Hospital

Zhuhai, Guangdong, China

Site Status RECRUITING

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

Nanning, Guangxi, China

Site Status RECRUITING

Affiliated Hospital of Zunyi Medical College

Zunyi, Guizhou, China

Site Status RECRUITING

The second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Site Status RECRUITING

Wuhan Asia Heart Hospital

Wuhan, Hubei, China

Site Status RECRUITING

Wuxi Third People's Hospital

Wuxi, Jiangsu, China

Site Status RECRUITING

Xuzhou Fourth People's Hospital

Xuzhou, Jiangsu, China

Site Status RECRUITING

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Site Status RECRUITING

The second Hospital of Jilin University

Changchun, Jilin, China

Site Status RECRUITING

General Hospital of Ningxia Medical University

Yinchuan, Ningxia, China

Site Status RECRUITING

The First Affiliated Hospital of Xi 'an Jiaotong University

Xi'an, Shaanxi, China

Site Status RECRUITING

Shanghai Zhongshan Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Central Hospital of Jiading District

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Central Hospital of Minhang District

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Central Hospital of Yangpu District

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Changhai Hospital of Second Military Medical University of Chinese PLA

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai chest hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai First People's Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Ninth People's Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Shidong Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Tongren Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Tenth People's Hospital of Tongji University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Tongji Hospital of Tongji University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Yueyang hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanxi cardiovascular hospital

Taiyuan, Shanxi, China

Site Status RECRUITING

Taiyuan central hospital

Taiyuan, Shanxi, China

Site Status RECRUITING

Tianjin Chest Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Karamay Central Hospital

Karamay, Xinjiang, China

Site Status RECRUITING

Yan'an Hospital of Kunming City

Kunming, Yunnan, China

Site Status ACTIVE_NOT_RECRUITING

Second Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, China

Site Status RECRUITING

Zhenjiang First People's Hospital

Hangzhou, Zhenjiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kang Yao, M.D., Ph.D.

Role: CONTACT

86+13818988550

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jingang Zheng

Role: primary

Yan Wang

Role: primary

Zheng Zhang

Role: primary

Yingling Zhou

Role: primary

Jingfeng Wang

Role: primary

Yingling Zhou

Role: primary

Guixin He

Role: primary

Bei Shi

Role: primary

Yongjun Li

Role: primary

Xi Su

Role: primary

Xiaoyan Wang

Role: primary

Yijie Huang

Role: primary

Zeqi Zheng

Role: primary

Bin Liu

Role: primary

Shaobin Jia

Role: primary

Yanni Wang

Role: primary

Kang Yao

Role: primary

86-13818988550

Yuxiang Dai

Role: backup

Xiangdong Xu

Role: primary

Wei Hu

Role: primary

Pengxiang Zheng

Role: primary

Xianxian Zhao

Role: primary

Chun Liang

Role: primary

Ben He

Role: primary

Shaowen Liu

Role: primary

Junfeng Zhang

Role: primary

Liuliu Feng

Role: primary

Chengxing Shen

Role: primary

Zening Shen

Role: primary

Yawei Xu

Role: primary

Xuebo Liu

Role: primary

Min Fan

Role: primary

Xuebin Han

Role: primary

Dengfeng Ma

Role: primary

Yin Liu

Role: primary

Xiaohong Liu

Role: primary

Jianan Wang

Role: primary

Guohui Zhang

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Wu R, Su Y, Liao J, Shen J, Ma Y, Gao W, Dong Z, Dai Y, Yao K, Ge J. Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early-Onset Coronary Atherosclerotic Disease. Clin Cardiol. 2024 Dec;47(12):e70066. doi: 10.1002/clc.70066.

Reference Type DERIVED
PMID: 39673281 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ZS-CV-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.